Examination and ultrasound
The clinician reviews your history and examines the neck. Ultrasound helps assess nodule features and lymph nodes; it is used to decide whether sampling or monitoring is appropriate.
surgical
A thyroid lump does not automatically mean cancer. Assessment helps establish what the lump is and whether observation, biopsy or specialist treatment is appropriate. This guide explains the decisions to discuss with your clinician.

Arrange medical assessment for a persistent neck lump, unexplained ongoing voice change or swallowing difficulty. These symptoms can also have non-cancerous causes. Severe breathing difficulty needs emergency help rather than a routine appointment.
Bring details of when the change appeared and any previous thyroid investigations. A clinician can decide the appropriate referral and urgency.
The clinician reviews your history and examines the neck. Ultrasound helps assess nodule features and lymph nodes; it is used to decide whether sampling or monitoring is appropriate.
Thyroid function tests assess hormone activity. Normal thyroid hormone results do not establish that a nodule is benign, and abnormal results alone do not diagnose cancer.
FNA, also called FNAC, samples cells. A result may be benign, malignant, suspicious, indeterminate or inadequate. Not every nodule requires a biopsy.
An uncertain result may lead to repeat sampling, selected molecular testing, monitoring or diagnostic surgery. Availability and usefulness of additional testing vary.
For some follicular-pattern lesions, cell sampling cannot distinguish a benign growth from cancer; examination of surgically removed tissue may be needed. Ask what the exact report category means for your case.
Ask for the exact pathology diagnosis. One treatment or prognosis statement should not be applied to every thyroid cancer type.
Specialist-led active surveillance may be an option for carefully selected small, low-risk papillary cancers. It involves agreed follow-up and criteria for intervention, rather than simply leaving a cancer unchecked.
A thyroid lobectomy removes one lobe; a total thyroidectomy removes the whole gland. The recommended extent depends on the diagnosis and risk assessment. Ask why a particular operation is proposed.
RAI is considered for selected differentiated cancers; it is not required for every patient and does not treat medullary or anaplastic cancer. Suitability requires specialist review.
Radiotherapy and systemic or targeted medicines may be used for selected advanced disease. The cancer type, molecular findings and clinical situation help guide the choice.
After total thyroidectomy, thyroid hormone replacement is needed. After removal of one lobe, the need for replacement is assessed individually. TSH targets are personalised; stronger suppression is not appropriate for everyone.
Follow-up may include examination, selected blood tests and ultrasound. The tests and schedule depend on the cancer type, treatment and response. Ask for a written plan and the contact route for new concerns.
Your specialist should explain outlook using your cancer type, extent, pathology and response to treatment. Population survival figures cannot predict an individual result, and a single percentage is not meaningful across all thyroid cancers.
Ask what the treatment aims to achieve, what uncertainty remains and how recurrence or progression would be monitored.
Do not assume an appointment for an initial assessment confirms the availability of endocrine surgery, nuclear medicine, RAI or oncology treatment at that hospital.
Contact the hospital to ask which clinician can provide an initial assessment or an appropriate referral for your concern. This page does not verify an onsite thyroid cancer multidisciplinary team, endocrine surgeon or nuclear medicine service.
No. A lump needs assessment, but a nodule is not by itself a cancer diagnosis.
No. Thyroid function tests assess hormone activity and cannot by themselves establish whether a nodule is cancerous.
No. The decision depends on ultrasound features and clinical assessment.
No. It means the sampled cells do not establish a definite benign or malignant diagnosis. Further assessment is needed.
No. Some follicular-pattern lesions require examination of surgically removed tissue to distinguish benign growth from cancer.
Not always. Specialist-led active surveillance may be considered for carefully selected small, low-risk papillary cancers.
No. RAI is used for selected differentiated cancers and does not treat medullary or anaplastic thyroid cancer.
It is needed after total thyroidectomy. After lobectomy, the need is assessed individually.
No. Outlook depends on the exact type, extent and response to treatment. Population figures do not predict an individual result.
No. Confirm the required specialist and treatment facility with the hospital, including any referral arrangements.
This is general patient information, not an individual diagnosis or treatment recommendation. No clinician review is claimed.
Find the Best Hospital Near You
H.No 15-24-212, MIG-212, Rd Number 1, K P H B Phase 1, Kukatpally, Hyderabad, Telangana 500072
H.No:-12-5-30, WhiteHouse, Moula Ali Rd, South Lalaguda, Tarnaka, Secunderabad, Telangana 500017